Fungal impacts on Earth's ecosystems
- PMID: 39910383
- PMCID: PMC11970531
- DOI: 10.1038/s41586-024-08419-4
Fungal impacts on Earth's ecosystems
Abstract
Over the past billion years, the fungal kingdom has diversified to more than two million species, with over 95% still undescribed. Beyond the well-known macroscopic mushrooms and microscopic yeast, fungi are heterotrophs that feed on almost any organic carbon, recycling nutrients through the decay of dead plants and animals and sequestering carbon into Earth's ecosystems. Human-directed applications of fungi extend from leavened bread, alcoholic beverages and biofuels to pharmaceuticals, including antibiotics and psychoactive compounds. Conversely, fungal infections pose risks to ecosystems ranging from crops to wildlife to humans; these risks are driven, in part, by human and animal movement, and might be accelerating with climate change. Genomic surveys are expanding our knowledge of the true biodiversity of the fungal kingdom, and genome-editing tools make it possible to imagine harnessing these organisms to fuel the bioeconomy. Here, we examine the fungal threats facing civilization and investigate opportunities to use fungi to combat these threats.
© 2025. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
Competing interests: D.W.D. and family hold founder shares in F2G, a University of Manchester spin-out antifungal discovery company, and share options in TFF Pharma. D.W.D. acts or has recently acted as a consultant to Pulmatrix, Pulmocide, Biosergen, TFF Pharmaceuticals, Pfizer, Omega, Novacyt, Rostra Therapeutics, MucPharm, Mundipharma, Lifemine and Cipla; chairs a Data Review Committee for Pulmocide; and acts as a Phase 1 Medical Monitor for Biosergen. In the past three years, D.W.D. has been paid for talks on behalf of BioRad, Basilea and Pfizer. J.E.S. is a paid consultant for Zymergen, Sincarne and Michroma. L.E.C. is a co-founder of and shareholder in Bright Angel Therapeutics, a platform company for the development of novel antifungal therapeutics, and a Science Advisor for Kapoose Creek, a company that harnesses the therapeutic potential of fungi.
Figures
References
-
- Baldrian P et al. Global Fungal Diversity Estimated from High-Throughput Sequencing. in Evolution of Fungi and Fungal-Like Organisms (eds. Pöggeler S & James T) 227–238 (Springer, Cham, 2023). doi: 10.1007/978-3-031-29199-9_10. - DOI
-
- Niskanen T et al. Pushing the frontiers of biodiversity research: Unveiling the global diversity, distribution, and conservation of fungi. Annu. Rev. Environ. Resour 48, 149–176 (2023).
-
- Brundrett MC & Tedersoo L Evolutionary history of mycorrhizal symbioses and global host plant diversity. New Phytol. 220, 1108–1115 (2018). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI130128/AI/NIAID NIH HHS/United States
- R01 AI172451/AI/NIAID NIH HHS/United States
- R01 DK121977/DK/NIDDK NIH HHS/United States
- R01 AI168370/AI/NIAID NIH HHS/United States
- R01 AI127375/AI/NIAID NIH HHS/United States
- R35 GM136379/GM/NIGMS NIH HHS/United States
- R01 AI052733/AI/NIAID NIH HHS/United States
- R01 AI133654/AI/NIAID NIH HHS/United States
- R01 AI163007/AI/NIAID NIH HHS/United States
- R01 AI165466/AI/NIAID NIH HHS/United States
- R01 DK113136/DK/NIDDK NIH HHS/United States
- R01 AI152078/AI/NIAID NIH HHS/United States
- R37 AI035681/AI/NIAID NIH HHS/United States
- R01 AI162789/AI/NIAID NIH HHS/United States
- R01 AI170543/AI/NIAID NIH HHS/United States
- R01 AI039115/AI/NIAID NIH HHS/United States
- U01 AI124299/AI/NIAID NIH HHS/United States
- R01 AI127548/AI/NIAID NIH HHS/United States
- R21 AI168672/AI/NIAID NIH HHS/United States
- R01 HL059842/HL/NHLBI NIH HHS/United States
- DP2 AI177927/AI/NIAID NIH HHS/United States
- R01 AI050113/AI/NIAID NIH HHS/United States
- T32 AI055397/AI/NIAID NIH HHS/United States
- K99 AI166094/AI/NIAID NIH HHS/United States
- R01 AI040996/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
